News
`Paradigm shift’: Luspatercept for MDS
- Author:
- Nancy A. Melville
In a first head-to-head comparison study, luspatercept for MDS significantly outperformed epoetin alfa in reducing transfusion dependence.
News
Diabetes, cholesterol meds use drops after bariatric surgery
- Author:
- Nancy A. Melville
Undergoing bariatric surgery was associated with a substantial and long-lasting reduction in the use of lipid-lowering and antidiabetic...
News
Immunotherapy plus chemo improves quality of life in NSCLC
- Author:
- Nancy A. Melville
The delays reported in time to definitive clinically meaningful deterioration “are particularly pertinent, given the anticipated continued...
News
Liquid biopsy assay can predict CRC recurrence early
- Author:
- Nancy A. Melville
CRC has a relatively high recurrence rate even after curative-intent therapies.
News
Weight loss linked to early death in older but healthy adults
- Author:
- Nancy A. Melville
“Clinicians should be aware that even minor weight loss of 5% or more in older adults without life-limiting illnesses can increase mortality risk...
News
Breast conservation safe even with multiple-site tumors
- Author:
- Nancy A. Melville
“This is an important study confirming that breast conservation is feasible and safe for women with multiple ipsilateral breast cancers, with...
News

Strong support for CBT as first-line treatment for insomnia in seniors
- Author:
- Nancy A. Melville
The American Academy of Sleep Medicine recommends CBT-I as first-line treatment for insomnia, with the key benefit being its exemplary safety...
News
New data on IV ketamine for resistant depression in the elderly
- Author:
- Nancy A. Melville
Overall, 48% of participants achieved a response, and 24% achieved remission of depressive symptoms following the first 4 weeks of twice-weekly...
News

Add-on antipsychotic beats switching meds in older adults with resistant depression
- Author:
- Nancy A. Melville
“These results are of great impact for clinicians managing older adults with treatment-resistant depression,” said Dr. Jennifer Gatchel.
News
Antipsychotic cuts Alzheimer’s-related agitation
- Author:
- Nancy A. Melville
Brexpiprazole will become the first drug to be approved for agitation in AD, doctor speculates.
News
Long-acting ART effective without viral suppression
- Author:
- Nancy A. Melville
“Instead of having the burden of taking a pill every day, patients with HIV can now have these choices of being able to forget about their...
News
Doxy PEP does not lower risk of STIs in cisgender women
- Author:
- Nancy A. Melville
Women are known to be at higher risk of infection because the lining of the vagina is thinner than the skin of the penis, allowing for easier...
News
Meningococcal vaccine shows benefit in STI prevention
- Author:
- Nancy A. Melville
“The duration of protective efficacy – a big thing in vaccines – is unknown. Still, this is really significant.”
News
Eight-week TB treatment strategy shows potential
- Author:
- Nancy A. Melville
“Clinicians will not feel comfortable with the short regimens at this point, but it is remarkable that so many patients did well with shorter...
News
Transplant vs. chemo: Similar AML survival rates
- Author:
- Nancy A. Melville
New study showed similar survival rates among AML patients treated solely with consolidation chemotherapy and those who received allogenic HCT.